D

D&H National Research Centers | Miami, FL

Research site
(Unclaimed)
Location
8485 Bird Road Suite 307, Miami, Florida, United States of America
Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Trials

10 of 20
Status: Active
Trial type: Interventional
Funder type: Industry

Filters
3
A Phase 3 Study Evaluating Efficacy and Safety of Lanifibranor Followed by an Active Treatment Extension in Adult Patients With (NASH) and Fibrosis Stages F2 and F3 ( NATiV3 )

This Phase 3 study is conducted to evaluate lanifibranor in adults with NASH and liver fibrosis histological stage F2 or F3

Enrolling
NASH - Nonalcoholic Steatohepatitis
Drug: Placebo
Drug: IVA337

The goal of this clinical trial is to see how well cenerimod is in reducing symptoms of Systemic Lupus Erythematous in adult patients with moderate t...

Enrolling
Lupus Erythematosus, Systemic
Drug: Cenerimod
Drug: Placebo

The main aims of the study are to see theside effects of Dexlansoprazole treatmenteffectiveness of Dexlansoprazole treatment in children having sympt...

Enrolling
Gastroesophageal Reflux Disease (GERD)
Drug: Dexlansoprazole

The main aims of the study are to check theside effects and effectiveness of Dexlansoprazole in healing erosive esophagitis (EE)side effects and effe...

Enrolling
Erosive Esophagitis
Drug: Dexlansoprazole
Locations recently updated

Atopic dermatitis (AD) is a skin condition that may cause a rash and itching due to inflammation of the skin. Therapies spread over the skin may not...

Active, not recruiting
Atopic Dermatitis
Drug: Upadacitinib
Drug: Dupilumab

Study of EDP-235 in Non-hospitalized Adults with Mild or Moderate COVID-19.

Enrolling
COVID-19
Drug: Placebo
Drug: EDP-235

The objective of this randomized, controlled trial is to evaluate the effects of consuming a pediatric oral nutritional supplement (ONS) plus dietary...

Enrolling
Undernutrition
Other: Oral Nutritional Supplement
Other: Dietary counseling

This is a phase 2 double-blind, randomized study of PBI-0451(Pomotrelvir) in nonhospitalized symptomatic adults with COVID-19. PBI-0451(Pomotrelvir)...

Active, not recruiting
COVID-19
Drug: PBI-0451 (Pomotrelvir)
Drug: Placebo

The study will evaluate the safety, tolerability, reactogenicity, and effectiveness of mRNA-1273.214 severe acute respiratory syndrome coronavirus 2...

Enrolling
SARS-CoV-2
Other: Placebo
Biological: mRNA-1273.214

This study will confirm the ability of Tc 99m tilmanocept imaging to predict clinical response in individuals with RA who are beginning anti-TNFα the...

Enrolling
Rheumatoid Arthritis
Drug: TC99m-tilmanocept

Trial conditions

COVID-19 (4 trials)
Gout (2 trials)
Systemic Lupus Erythemat... (2 trials)
Arthritis (1 trial)
Atopic Dermatitis (1 trial)
Clostridium Infections (1 trial)
Communicable Diseases (1 trial)
Coronavirus Infections (1 trial)
Dermatitis (1 trial)
Eczema (1 trial)

And 13 more

Clinical trials

Find clinical trialsTrials by location

Resources

© Copyright 2024 Veeva Systems